Assunta Sartor
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Antimicrobial Resistance in Staphylococcus 12
- Antifungal resistance and susceptibility 9
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 7
- Epidemiology 25
- Co-authors
- Matteo Bassetti (25 shared papers)Elda Righi (21 shared papers)Claudio Scarparo (11 shared papers)Maria Merelli (6 shared papers)Mario Tumbarello (5 shared papers)Enrico Maria Trecarichi (4 shared papers)Filippo Ansaldi (4 shared papers)Federico Pea (9 shared papers)
- Journals
- International Journal of Antimicrobial Agents (3 papers)Clinical Microbiology and Infection (3 papers)Journal of Clinical Microbiology (3 papers)Diagnostic Microbiology and Infectious Disease (2 papers)PLoS ONE (2 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Assunta Sartor
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 89
- Applied Microbiology and Biotechnology 169
- Infectious Diseases 723
- Molecular Medicine 167
- Clinical Biochemistry 178
- Epidemiology 522
Countries citing papers authored by Assunta Sartor
This map shows the geographic impact of Assunta Sartor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assunta Sartor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assunta Sartor more than expected).
Fields of papers citing papers by Assunta Sartor
This network shows the impact of papers produced by Assunta Sartor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assunta Sartor. The network helps show where Assunta Sartor may publish in the future.
Co-authors
The 25 scholars most cited alongside Assunta Sartor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 197 | |
| 2 | 2013 | 177 | |
| 3 | 2015 | 85 | |
| 4 | 2016 | 57 | |
| 5 | 2017 | 56 | |
| 6 | 2013 | 52 | |
| 7 | 2017 | 49 | |
| 8 | 2021 | 37 | |
| 9 | 2022 | 35 | |
| 10 | 2016 | 33 | |
| 11 | 2018 | 29 | |
| 12 | 2008 | 27 | |
| 13 | 2018 | 21 | |
| 14 | 2019 | 19 | |
| 15 | 2017 | 18 | |
| 16 | 2020 | 17 | |
| 17 | 2022 | 17 | |
| 18 | 2017 | 17 | |
| 19 | 2019 | 16 | |
| 20 | 2014 | 16 |
About Assunta Sartor
Assunta Sartor is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Pharmacology and Molecular Medicine, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (12 papers), Antifungal resistance and susceptibility (9 papers), COVID-19 Clinical Research Studies (8 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (7 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Long-Term Effects of COVID-19 (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (169 citations), Infectious Diseases (723 citations), Molecular Medicine (167 citations), Clinical Biochemistry (178 citations) and Epidemiology (522 citations). Assunta Sartor has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Matteo Bassetti, Elda Righi, Claudio Scarparo, Maria Merelli, Mario Tumbarello, Enrico Maria Trecarichi, Filippo Ansaldi, Federico Pea, Maurizio Sanguinetti and Jordi Rello. Their work appears in journals such as International Journal of Antimicrobial Agents, Clinical Microbiology and Infection, Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.